PMC:7647877 / 19335-19651 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T269","span":{"begin":18,"end":32},"obj":"Body_part"},{"id":"T270","span":{"begin":57,"end":66},"obj":"Body_part"},{"id":"T271","span":{"begin":189,"end":198},"obj":"Body_part"},{"id":"T272","span":{"begin":204,"end":213},"obj":"Body_part"}],"attributes":[{"id":"A269","pred":"fma_id","subj":"T269","obj":"http://purl.org/sig/ont/fma/fma20110"},{"id":"A270","pred":"fma_id","subj":"T270","obj":"http://purl.org/sig/ont/fma/fma63880"},{"id":"A271","pred":"fma_id","subj":"T271","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A272","pred":"fma_id","subj":"T272","obj":"http://purl.org/sig/ont/fma/fma63880"}],"text":"The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T57","span":{"begin":18,"end":32},"obj":"Body_part"},{"id":"T58","span":{"begin":26,"end":32},"obj":"Body_part"},{"id":"T59","span":{"begin":83,"end":95},"obj":"Body_part"}],"attributes":[{"id":"A57","pred":"uberon_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/UBERON_0001013"},{"id":"A58","pred":"uberon_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"A59","pred":"uberon_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/UBERON_0035818"}],"text":"The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T121","span":{"begin":291,"end":310},"obj":"Disease"}],"attributes":[{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0005066"}],"text":"The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T284","span":{"begin":18,"end":32},"obj":"http://purl.obolibrary.org/obo/UBERON_0001013"},{"id":"T285","span":{"begin":57,"end":66},"obj":"http://purl.obolibrary.org/obo/CL_0000136"},{"id":"T286","span":{"begin":92,"end":95},"obj":"http://purl.obolibrary.org/obo/UBERON_0001013"},{"id":"T287","span":{"begin":204,"end":213},"obj":"http://purl.obolibrary.org/obo/CL_0000136"}],"text":"The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T38","span":{"begin":57,"end":78},"obj":"Phenotype"},{"id":"T39","span":{"begin":177,"end":185},"obj":"Phenotype"}],"attributes":[{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0030759"},{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0001050"}],"text":"The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T120","span":{"begin":0,"end":316},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"568","span":{"begin":67,"end":78},"obj":"Disease"},{"id":"569","span":{"begin":291,"end":310},"obj":"Disease"}],"attributes":[{"id":"A568","pred":"tao:has_database_id","subj":"568","obj":"MESH:D006984"},{"id":"A569","pred":"tao:has_database_id","subj":"569","obj":"MESH:D008659"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The disruption of adipose tissue processes, as occurs in adipocyte hypertrophy and visceral fat accumulation, results in the production of pro-inflammatory components (like the plethora of cytokines) and adipocyte factors dysregulation, which may be both genesis and/or main contributors to metabolic disorders [39]."}